Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Colorcon
Healthtrust
Covington
Farmers Insurance
Citi
Chubb
Cerilliant
Harvard Business School

Generated: April 26, 2018

DrugPatentWatch Database Preview

Naratriptan hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for naratriptan hydrochloride and what is the scope of naratriptan hydrochloride freedom to operate?

Naratriptan hydrochloride
is the generic ingredient in two branded drugs marketed by Glaxosmithkline Llc, Apotex Corp, Casi Pharms Inc, Heritage Pharms Inc, Mylan Pharms Inc, Orchid Hlthcare, Paddock Llc, Sun Pharm Inds Ltd, Teva Pharms, and West-ward Pharms Int, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for naratriptan hydrochloride. Six suppliers are listed for this compound.
Pharmacology for naratriptan hydrochloride
Synonyms for naratriptan hydrochloride
10X8X4P12Z
143388-64-1
1H-Indole -5-ethanesulfonamide,N-methyl-3-(1-methyl-4-piperidinyl)-, monohydrochloride
1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, monohydrochloride
2-[3-(1-methyl-piperidin-4-yl)-1H-indol-5-yl]-ethanesulfonic acid methylamide Hydrochloride
388N641
A808063
AB0033380
ABP001029
AC-5014
AC1L1U3C
AC1Q3ETY
AK398843
AKOS005145806
Amerge
Amerge (TN)
AN-5269
API0000686
AT-19354
AWEZYKMQFAUBTD-UHFFFAOYSA-N
C17H25N3O2S.HCl
CAS-143388-64-1
CCG-221770
CHEBI:7479
CHEMBL1200601
CS-2132
CTK8E8530
D00674
DSSTox_CID_28990
DSSTox_GSID_49064
DSSTox_RID_83255
DTXSID6049064
FT-0672649
GG-548
GR 85548A
GR-85548A
HY-B0197A
J-007804
KS-00000OQE
LS-172502
MFCD08141821
MLS006010726
MolPort-003-849-333
N-methyl-2-(3-(1-methylpiperidin-4-yl)-1H-indol-5-yl)ethanesulfonamide hydrochloride
N-methyl-2-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]ethanesulfonamide hydrochloride
N-Methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]ethanesulfonamide Hydrochloride
N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide hydrochloride
N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide;hydrochloride
N-Methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide hydrochloride
n-methyl-3-(1-methyl-4-piperidinyl)-1h-indole-5-ethanesulphonamide hydrochloride
N-Methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulphonamide, hydrochloride
N-Methyl-3-(1-methyl-4-piperidyl)indole-5-ethanesulfonamide monohydrochloride
Naramig
Naratriptan (hydrochloride)
Naratriptan HCl
Naratriptan hydrochloride (JAN/USAN)
Naratriptan hydrochloride [USAN:USP]
Naratriptan hydrochloride [USAN]
Naratriptan hydrochloride, >=98% (HPLC)
Naratriptan hydrochloride, United States Pharmacopeia (USP) Reference Standard
naratriptanhydrochloride
NCGC00181786-01
NCGC00181786-02
NCGC00261151-01
PubChem16865
Q-201448
QCR-255
RB3224
RTC-070946
s1488
SCHEMBL41527
SMR002529694
TC-070946
Tox21_113617
Tox21_113617_1
Tox21_500466
UNII-10X8X4P12Z
VA11356
X6918

US Patents and Regulatory Information for naratriptan hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 090381-001 Jul 7, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Paddock Llc NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 091326-001 Jul 8, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Casi Pharms Inc NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 090288-001 Jul 7, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex Corp NARATRIPTAN naratriptan hydrochloride TABLET;ORAL 091373-002 Apr 22, 2011 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for naratriptan hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc AMERGE naratriptan hydrochloride TABLET;ORAL 020763-002 Feb 10, 1998 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Llc AMERGE naratriptan hydrochloride TABLET;ORAL 020763-001 Feb 10, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Moodys
Dow
US Department of Justice
Teva
Federal Trade Commission
UBS
Harvard Business School
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.